Prediction of cognitive decline in healthy older adults using fMRI.

Journal of Alzheimer's Disease : JAD
John L WoodardStephen M Rao

Abstract

Few studies have examined the extent to which structural and functional MRI, alone and in combination with genetic biomarkers, can predict future cognitive decline in asymptomatic elders. This prospective study evaluated individual and combined contributions of demographic information, genetic risk, hippocampal volume, and fMRI activation for predicting cognitive decline after an 18-month retest interval. Standardized neuropsychological testing, an fMRI semantic memory task (famous name discrimination), and structural MRI (sMRI) were performed on 78 healthy elders (73% female; mean age = 73 years, range = 65 to 88 years). Positive family history of dementia and presence of one or both apolipoprotein E (APOE) ε4 alleles occurred in 51.3% and 33.3% of the sample, respectively. Hippocampal volumes were traced from sMRI scans. At follow-up, all participants underwent a repeat neuropsychological examination. At 18 months, 27 participants (34.6%) declined by at least 1 SD on one of three neuropsychological measures. Using logistic regression, demographic variables (age, years of education, gender) and family history of dementia did not predict future cognitive decline. Greater fMRI activity, absence of an APOE ε4 allele, and larger h...Continue Reading

Citations

Dec 4, 2012·Journal of the International Neuropsychological Society : JINS·Nathan HantkeStephen M Rao
Apr 6, 2011·Psychological Bulletin·Timothy A Salthouse
May 22, 2013·Neuropsychology·Gali H WeissbergerTamar H Gollan
Jun 26, 2012·The Journal of Clinical Endocrinology and Metabolism·Alison Berent-SpillsonYolanda R Smith
May 6, 2014·Frontiers in Aging Neuroscience·J Carson SmithStephen M Rao
Feb 21, 2014·Journal of Clinical and Experimental Neuropsychology·Michael A SugarmanStephen M Rao
Dec 3, 2016·Journal of the International Neuropsychological Society : JINS·Melissa A LancasterStephen M Rao
Jan 31, 2014·Current Directions in Psychological Science·Elliot T Berkman, Emily B Falk
Jul 12, 2018·Menopause : the Journal of the North American Menopause Society·Alison Berent-SpillsonYolanda R Smith
Oct 9, 2012·International Journal of Geriatric Psychiatry·Ilan Dar-NimrodPaul R Duberstein
Feb 15, 2013·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Peter J Snyder
May 1, 2011·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Nina B SilverbergTanis J Ferman
Jun 24, 2020·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Richard ShervaRobert C Green
Jun 19, 2013·Journal of Cognitive Neuroscience·Andrew R BenderNaftali Raz
Jun 19, 2020·Computational Intelligence and Neuroscience·Yvonne HöllerEugen Trinka
Jan 14, 2021·Pflügers Archiv : European journal of physiology·Lucy BeishonThompson G Robinson
Sep 18, 2020·Behavioural Brain Research·Elizabeth R PaitelKristy A Nielson
Oct 8, 2021·Frontiers in Aging Neuroscience·Deborah L HarringtonRoland R Lee

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.